Repligen Corporation Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Boston, MA USA
Total Funding:$242.6M
Industry:Biotech
Founded:1981
Lead Investor(s):J.P. Morgan Securities LLC, Stephens Inc

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Repligen Corporation's estimated annual revenue is currently $119.7M per year.(?)
  • Repligen Corporation received $138.0M in venture funding in June 2017.
  • Repligen Corporation's estimated revenue per employee is $155,000
  • Repligen Corporation's total funding is $242.6M.

Employee Data

  • Repligen Corporation has 772 Employees.(?)
  • Repligen Corporation grew their employee count by 31% last year.
  • Repligen Corporation currently has 4 job openings.

Repligen is a bioprocessing-focused life sciences company bringing over 35 years of expertise and innovation to our customers. We are inspiring advances in bioprocessing through the development and commercialization of high-value products and flexible solutions that address critical steps in the production of biologic drugs, principally monoclonal antibodies. Our manufacturing facilities are located at our Waltham, Massachusetts headquarters in the USA, and in Lund, Sweden, Weingarten, Germany , Rancho Dominguez, CA and Shrewsbury, MA. We market our products globally through a direct commercial organization in the U.S., Europe and Asia, as well as through strategic partners in select markets.

keywords:Biotechnology,Healthcare,Pharmaceuticals